Education
About Us
Working with TipRanks
Follow Us
Cellebrite DI (CLBT)
NASDAQ:CLBT
Earnings Data
Report Date
Aug 06, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.08Last Year’s EPS
-0.12Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Date:May 14, 2025
|% Change Since: -15.66%
|Next Earnings Date:Aug 06, 2025
Earnings Call Sentiment|Neutral
Cellebrite showed strong growth in several key areas, including ARR and specific product lines like Guardian, and hosted successful events and product releases. However, challenges in the U.S. Federal and EMEA markets moderated some of the positive impacts. Despite these challenges, the company remains optimistic about future growth, particularly in the second half of the year.Company Guidance
During the Cellebrite First Quarter 2025 Financial Results Conference Call, the company reported a strong 23% year-on-year growth in Annual Recurring Revenue (ARR), reaching $408 million, and a 34% increase in adjusted EBITDA, resulting in a 22% margin. The first quarter revenue amounted to $107.5 million, marking a 20% year-over-year increase, primarily driven by a 21% rise in subscription revenue. The gross retention rate held steady at 92%, with notable retention in the U.S. and Asia Pacific regions. Despite challenges in the U.S. Federal and EMEA sectors, the company remains optimistic about future growth, projecting second quarter ARR between $416 million to $426 million, and revenue of $110 million to $116 million. The full-year guidance remains unchanged, anticipating continued expansion, especially in the U.S. state and local, Latin America, and Asia Pacific markets. The firm highlighted an ongoing focus on strategic areas like Guardian and Pathfinder solutions, with Guardian achieving over 100% ARR growth for three consecutive quarters.Strong ARR and Revenue Growth
Cellebrite delivered a 23% year-on-year ARR growth, reaching $408 million, and a 20% increase in revenue to $107.5 million for the first quarter of 2025.
Significant Growth in Guardian Product
Guardian achieved its third consecutive quarter of over 100% ARR growth, reflecting strong adoption and interest in this product.
Successful User Conference and Product Release
Cellebrite hosted its first user conference with around 700 attendees and launched the Spring 2025 product release, featuring cloud and AI innovations.
U.S. State and Local, LATAM and Asia Pacific Growth
Cellebrite saw strong performance and momentum in the U.S. state and local, LATAM, and Asia Pacific regions.
Robust Financial Performance
The company achieved a 34% year-on-year growth in adjusted EBITDA, resulting in a 22% margin.
CLBT Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CLBT Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 14, 2025 | $20.12 | $17.81 | -11.48% |
Feb 13, 2025 | $24.92 | $21.70 | -12.92% |
Nov 06, 2024 | $19.15 | $19.09 | -0.31% |
Aug 15, 2024 | $13.94 | $14.96 | +7.32% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Cellebrite DI (CLBT) report earnings?
Cellebrite DI (CLBT) is schdueled to report earning on Aug 06, 2025, TBA Not Confirmed.
What is Cellebrite DI (CLBT) earnings time?
Cellebrite DI (CLBT) earnings time is at Aug 06, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CLBT EPS forecast?
CLBT EPS forecast for the fiscal quarter 2025 (Q2) is 0.08.